Join to view full profile
250 25th Ave NSte 100Nashville, TN 37203
Phone+1 615-986-7600
Fax+1 615-986-7601
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. William Donnellan, MD is an oncologist in Nashville, Tennessee. He is currently licensed to practice medicine in Tennessee, Georgia, and Alabama.
Education & Training
University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014- University of Alabama Medical CenterResidency, Internal Medicine, 2008 - 2011
University of Alabama School of MedicineClass of 2008
Certifications & Licensure
GA State Medical License 2020 - 2028
TN State Medical License 2014 - 2027
AL State Medical License 2009 - 2021
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2016-2017
Publications & Presentations
PubMed
- 12 citationsA phase 3b study of venetoclax and azacitidine or decitabine in an outpatient setting in patients with acute myeloid leukemia.Sudhir Manda, Bertrand M Anz 3rd, Christopher Benton, E Randolph Broun, Habte A Yimer
Hematological Oncology. 2024-05-01 - 17 citationsFirst-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome.Rupa Narayan, Ana Alfonso Piérola, William B Donnellan, Antonieta Molero Yordi, Maher Abdul-Hay
Clinical and Translational Science. 2024-03-01 - 1 citationsDeterminants of Outcomes for Acute Myeloid Leukemia Patients Treated in a Community-Based Specialized Versus Non-Specialized Hospital Setting.Minoo Battiwalla, Ju-Hsien Chao, Tonya Cox, Jose Carlos Cruz, William B Donnellan
Clinical Hematology International. 2024-01-01
Press Mentions
Sarah Cannon to Present Latest Cancer Research Insights at 2019 American Society of Clinical Oncology’s Annual MeetingMay 30th, 2019
